Due to its central positioning in cancer survival, there is an ongoing focus to develop anti-cancer therapies targeting MCL1, including small molecule inhibitors12–14, stapled peptides15,16, antisense oligonucleotides17, and reversible covalent inhibitors18. Here, MCL1 is linked to cancer.